Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug ...

Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for its generic version of ...

Vadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for ...

Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for its generic version of ...

25). These new data reinforce the use of LODOCO ® (colchicine, 0.5 mg tablet), the first anti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardial infarction (MI), ...

MANILA – The Food and Drug Administration (FDA) has expanded the list of medicines for non-communicable diseases (NCDs) exempted from value-added tax (VAT). In a public advisory on Friday, the FDA ...

The regulator, in a notification on 5 March, directed drug ... of bisoprolol fumarate and amlodipine besilate tablets at ₹8.54 apiece. This combination drug is used to treat people with high ...

Another strategy presented involves a four-drug full-dose combination in patients ... In the standard care group, patients started with amlodipine (5 mg), which was stepped up at monthly intervals ...

The starting dose is 2.5 mg daily because people in these groups may process amlodipine differently or more slowly. Both amlodipine and lisinopril are taken by mouth and are available in tablet and ...

For people with liver disease: The recommended dosage is 2.5 mg taken once per day. Your liver processes amlodipine. If your liver isn’t working well, more of this drug may stay in your body longer.

For people with liver disease: The recommended dosage is 2.5 mg taken once per day. Your liver processes amlodipine. If your liver isn’t working well, more of this drug may stay in your body longer.